Multicenter Phase I/II Study of Cetuximab With Paclitaxel and Carboplatin in Untreated Patients With Stage IV Non–Small-Cell Lung Cancer Data from 1,066 patients recruited from nine European centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback